Search

Author/Creator Nakao, Satoshi

12. Serum high-mobility group box 1 as a predictive marker for cytotoxic chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease. (October 2020)

Authors:
Nakao, Satoshi; Yamaguchi, Kakuhiro; Iwamoto, Hiroshi; Sakamoto, Shinjiro; Horimasu, Yasushi; Masuda, Takeshi; Miyamoto, Shintaro; Nakashima, Taku; Ohshimo, Shinichiro; Fujitaka, Kazunori; Hamada, Hironobu; Hattori, Noboru
Journal:
Respiratory medicine
Issue:
Volume 172(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. Vonoprazan‐ vs proton‐pump inhibitor‐based first‐line 7‐day triple therapy for clarithromycin‐susceptible Helicobacter pylori: A multicenter, prospective, randomized trial. Issue 2 (21st December 2017)

Authors:
Sue, Soichiro; Ogushi, Marina; Arima, Isao; Kuwashima, Hirofumi; Nakao, Satoshi; Naito, Makoto; Komatsu, Kazuo; Kaneko, Hiroaki; Tamura, Toshihide; Sasaki, Tomohiko; Kondo, Masaaki; Shibata, Wataru; Maeda, Shin
Journal:
Helicobacter
Issue:
Volume 23:Issue 2(2018)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗